Results 1 - 20 of 30 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
Refined by:
resource type:
Standards
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Standards
|
|
Rimegepant for preventing migraineNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 2 |
Material Type: Standards
|
|
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatmentsNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 3 |
Material Type: Standards
|
|
Avatrombopag for treating primary chronic immune thrombocytopeniaNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 4 |
Material Type: Standards
|
|
Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 5 |
Material Type: Standards
|
|
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 6 |
Material Type: Standards
|
|
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin geneNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 7 |
Material Type: Standards
|
|
Lenalidomide with rituximab for previously treated follicular lymphomaNICE Guidance, 2020Copyrights: © NICE 2020 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 8 |
Material Type: Standards
|
|
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 9 |
Material Type: Standards
|
|
Ponesimod for treating relapsing–remitting multiple sclerosisNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 10 |
Material Type: Standards
|
|
Nintedanib for treating progressive fibrosing interstitial lung diseasesNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 11 |
Material Type: Standards
|
|
Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary careNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 12 |
Material Type: Standards
|
|
Berotralstat for preventing recurrent attacks of hereditary angioedemaNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 13 |
Material Type: Standards
|
|
PLGF-based testing to help diagnose suspected preterm pre-eclampsiaNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 14 |
Material Type: Standards
|
|
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancerNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 15 |
Material Type: Standards
|
|
Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapyNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 16 |
Material Type: Standards
|
|
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 17 |
Material Type: Standards
|
|
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoeaNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 18 |
Material Type: Standards
|
|
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 19 |
Material Type: Standards
|
|
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 20 |
Material Type: Standards
|
|
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancerNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
Results 1 - 20 of 30 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 2018 (1)
- 2018 To 2018 (3)
- 2019 To 2019 (2)
- 2020 To 2021 (9)
- After 2021 (16)
-
More options
New Records
Subject
- Economic Models (29)
- Clinical Practice Guidelines (27)
- Committees (26)
- Marketing (24)
- Clinical Trials (13)
- Chemotherapy (13)
- Patients (12)
- Clinical Medicine (11)
- Quality Of Life (9)
- Cancer Therapies (9)
- Cost Analysis (8)
- Drug Dosages (5)
- Decision Making (5)
- Metastasis (5)
- Palliative Care (4)
- Mutation (4)
- Costs (3)
- Leukemia (3)
- Accuracy (3)
- Diabetes (3)
-
More options
Databases
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||